2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Malignant Ascites: new trials by email Literature Review of Malignant Ascites trials Research Report on Malignant Ascites
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers Catumaxomab, Prednisolone - Cancer, Neoplasms | Phase 3 | Completed | Neovii Biotech | 230 | 2008-12-01 | 2012-10-03 |
| Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group Catumaxomab (Removab), paracentesis - EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast), Malignant Ascites | Phase 2 / Phase 3 | Completed | Neovii Biotech | 258 | 2004-09-01 | 2009-02-05 |
Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
catumaxomab (2) · Paracentesis (1) · Prednisolone (1)
Neovii Biotech (2)
France (1) · Germany (1) · Italy (1) · Spain (1)
Florian Lordick, PD Dr. med. (1)